Financial Snapshot

Revenue
$40.97M
TTM
Gross Margin
Net Earnings
-$39.86M
TTM
Current Assets
$187.6M
Q3 2024
Current Liabilities
$101.0M
Q3 2024
Current Ratio
185.76%
Q3 2024
Total Assets
$244.2M
Q3 2024
Total Liabilities
$114.1M
Q3 2024
Book Value
$130.2M
Q3 2024
Cash
$32.42M
Q3 2024
P/E
-8.002
Nov 29, 2024 EST
Free Cash Flow
$43.07M
TTM

Revenues

Revenues

Loading...

Revenue YoY Change

Loading...

Revenues

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013
Revenue $14.80M $3.935M $0.00 $15.40M $111.0M $7.200M $20.30M $23.20M $39.10M $30.30M $8.600M
YoY Change 276.14% -100.0% -86.13% 1441.67% -64.53% -12.5% -40.66% 29.04% 252.33%

Expenses

Cost Of Revenues

Loading...

Gross Profit

Loading...

Gross Profit Margin

Loading...

Gross Profit

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013
Revenue $14.80M $3.935M $0.00 $15.40M $111.0M $7.200M $20.30M $23.20M $39.10M $30.30M $8.600M
Cost Of Revenue
Gross Profit
Gross Profit Margin

Selling, General & Admin Expense

Loading...

Research & Development

Loading...

Depreciation, Depletion & Amortization

Loading...

SGA Expense to Gross Profit Ratio

Loading...

R&D To Gross Profit Ratio

Loading...

DDA To Gross Profit Ratio

Loading...

Operating Expenses Total

Loading...

Operating Profits/Loss

Loading...

Operational Expenses

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013
Selling, General & Admin $10.58M $9.582M $10.88M $11.10M $9.400M $7.600M $6.300M $4.700M $2.000M $2.000M $1.800M
YoY Change 10.37% -11.92% -1.99% 18.09% 23.68% 20.63% 34.04% 135.0% 0.0% 11.11%
% of Gross Profit
Research & Development $54.61M $60.30M $62.28M $59.50M $50.40M $44.30M $32.70M $25.50M $16.80M $15.80M $16.90M
YoY Change -9.44% -3.18% 4.68% 18.06% 13.77% 35.47% 28.24% 51.79% 6.33% -6.51%
% of Gross Profit
Depreciation & Amortization $2.215M $2.359M $2.406M $1.970M $1.690M $960.0K $580.0K $280.0K $290.0K $300.0K $290.0K
YoY Change -6.1% -1.95% 22.13% 16.57% 76.04% 65.52% 107.14% -3.45% -3.33% 3.45%
% of Gross Profit
Operating Expenses $54.61M $60.30M $79.01M $76.70M $66.50M $56.70M $42.80M $33.70M $20.50M $19.60M $20.10M
YoY Change -9.44% -23.68% 3.01% 15.34% 17.28% 32.48% 27.0% 64.39% 4.59% -2.49%
Operating Profit
YoY Change

Interest Expenses

Loading...

Interest Expenses To Operating Income %

Loading...

Other Expense/Income

Loading...

Interest & Other Expense/Income

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013
Interest Expense -$599.0K $107.0K $6.017M -$700.0K -$1.600M -$300.0K $200.0K $3.400M $1.600M $0.00 $300.0K
YoY Change -659.81% -98.22% -959.57% -56.25% 433.33% -250.0% -94.12% 112.5% -100.0%
% of Operating Profit
Other Income/Expense, Net $0.00 $0.00 $2.500M -$1.100M -$4.100M
YoY Change -100.0% -327.27% -73.17%

Income/Loss

Pretax Income

Loading...

Income Tax

Loading...

Net Profits/Loss

Loading...

Pretax Income YoY Change

Loading...

Income Tax Rate

Loading...

Net Profits/Loss YoY Change

Loading...

Basic EPS

Loading...

Net Income To Revenue Ratio

Loading...

Pretax & Net Income

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013
Pretax Income -$54.22M -$70.74M -$72.99M -$61.90M $45.40M -$51.00M -$26.40M -$7.100M $20.30M $10.70M -$11.20M
YoY Change -23.35% -3.09% 17.92% -236.34% -189.02% 93.18% 271.83% -134.98% 89.72% -195.54%
Income Tax $10.00K $13.00K -$3.000K $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
% Of Pretax Income 0.0% 0.0% 0.0%
Net Earnings -$54.23M -$70.75M -$72.99M -$61.90M $45.40M -$51.00M -$26.40M -$7.100M $20.30M $10.70M -$11.20M
YoY Change -23.35% -3.06% 17.92% -236.34% -189.02% 93.18% 271.83% -134.98% 89.72% -195.54%
Net Earnings / Revenue -366.41% -1798.04% -401.95% 40.9% -708.33% -130.05% -30.6% 51.92% 35.31% -130.23%
Basic Earnings Per Share
Diluted Earnings Per Share -$0.64 -$0.85 -$973.8K -$860.9K $638.5K -$825.2K -$462.3K -$141.7K $376.6K $198.5K -$207.8K

Assets & Liabilities

Cash & Short-Term Investments

Loading...

Cash & Equivalents

Loading...

Cash To Operating Expenses Ratio

Loading...

Inventory

Loading...

Receivables

Loading...

Total Short-Term Assets

Loading...

Property, Plant And Equipment

Loading...

Long-Term Investments

Loading...

Total Long-Term Assets

Loading...

Total Assets

Loading...

Net Income To Total Assets Percentage

Loading...

Accounts Payable

Loading...

Short-Term Debt

Loading...

Long Term Debt Due

Loading...

Total Short-Term Liabilities

Loading...

Long-Term Debt

Loading...

Other Long-Term Liabilities

Loading...

Total Long-Term Liabilities

Loading...

Total Liabilities

Loading...

Short-Term To Long-Term Debt Ratio

Loading...

Short-Term Assets To Debt Ratio

Loading...

Long-Term Debt To Net Income Ratio

Loading...

Assets & Liabilities

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013
Cash & Short-Term Investments $103.0M $122.6M $198.2M $225.9M $288.6M $186.5M $124.4M $152.2M $76.50M $3.300M $11.30M
YoY Change -15.94% -38.16% -12.25% -21.73% 54.75% 49.92% -18.27% 98.95% 2218.18% -70.8%
Cash & Equivalents $78.49M $31.59M $82.22M $160.9M $193.6M
Short-Term Investments $24.55M $91.00M $116.0M $65.00M $95.00M $30.00M
Other Short-Term Assets $6.437M $4.708M $3.015M $4.000M $2.800M $2.400M $1.400M $1.300M $2.500M $400.0K $500.0K
YoY Change 36.72% 56.15% -24.63% 42.86% 16.67% 71.43% 7.69% -48.0% 525.0% -20.0%
Inventory
Prepaid Expenses
Receivables $15.05M $408.0K $975.0K $1.600M $1.100M $3.700M $2.800M $900.0K $0.00 $100.0K $0.00
Other Receivables $622.0K $392.0K $428.0K $300.0K $300.0K $400.0K $900.0K $500.0K $300.0K $25.90M $200.0K
Total Short-Term Assets $125.2M $128.1M $202.6M $231.8M $292.8M $192.9M $129.5M $154.9M $79.30M $29.70M $12.00M
YoY Change -2.3% -36.79% -12.58% -20.83% 51.79% 48.96% -16.4% 95.33% 167.0% 147.5%
Property, Plant & Equipment $6.884M $7.067M $8.030M $6.600M $6.200M $3.300M $2.400M $1.100M $500.0K $500.0K $700.0K
YoY Change -2.59% -11.99% 21.67% 6.45% 87.88% 37.5% 118.18% 120.0% 0.0% -28.57%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $361.0K $361.0K $363.0K $300.0K $300.0K $0.00
YoY Change 0.0% -0.55% 21.0% 0.0%
Other Assets $300.0K $100.0K $100.0K $100.0K $100.0K $100.0K
YoY Change 200.0% 0.0% 0.0% 0.0% 0.0%
Total Long-Term Assets $57.66M $57.84M $58.81M $6.900M $6.500M $3.700M $2.500M $1.200M $600.0K $600.0K $800.0K
YoY Change -0.32% -1.64% 752.3% 6.15% 75.68% 48.0% 108.33% 100.0% 0.0% -25.0%
Total Assets $182.8M $185.9M $261.4M $238.7M $299.3M $196.6M $132.0M $156.1M $79.90M $30.30M $12.80M
YoY Change
Accounts Payable $1.679M $929.0K $2.003M $2.200M $100.0K $2.000M $1.100M $4.000M $1.700M $1.600M $1.200M
YoY Change 80.73% -53.62% -8.95% 2100.0% -95.0% 81.82% -72.5% 135.29% 6.25% 33.33%
Accrued Expenses $11.09M $9.417M $16.74M $11.10M $11.80M $10.40M $8.300M $5.400M $4.300M $2.600M $2.700M
YoY Change 17.73% -43.73% 50.77% -5.93% 13.46% 25.3% 53.7% 25.58% 65.38% -3.7%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $672.0K $548.0K $570.0K $400.0K $1.100M $300.0K
YoY Change 22.63% -3.86% 42.5% -63.64% 266.67%
Total Short-Term Liabilities $13.58M $11.48M $20.03M $14.00M $17.50M $13.10M $9.800M $9.900M $6.100M $4.400M $7.900M
YoY Change 18.25% -42.67% 43.04% -20.0% 33.59% 33.67% -1.01% 62.3% 38.64% -44.3%
Long-Term Debt $2.825M $2.253M $2.340M $1.800M $1.800M $200.0K $400.0K $0.00 $0.00 $0.00 $0.00
YoY Change 25.39% -3.72% 30.0% 0.0% 800.0% -50.0%
Other Long-Term Liabilities $5.770M $3.213M $7.098M $7.500M $7.500M $5.700M $5.000M $3.800M $2.800M $2.400M $900.0K
YoY Change 79.58% -54.73% -5.36% 0.0% 31.58% 14.0% 31.58% 35.71% 16.67% 166.67%
Total Long-Term Liabilities $8.595M $5.466M $9.438M $9.300M $9.300M $5.900M $5.400M $3.800M $2.800M $2.400M $900.0K
YoY Change 57.24% -42.09% 1.48% 0.0% 57.63% 9.26% 42.11% 35.71% 16.67% 166.67%
Total Liabilities $22.17M $16.95M $29.46M $23.30M $26.80M $18.90M $15.20M $13.70M $8.900M $6.800M $8.800M
YoY Change 30.83% -42.48% 26.45% -13.06% 41.8% 24.34% 10.95% 53.93% 30.88% -22.73%

Ownership

Basic Shares Outstanding

Loading...

Diluted Shares Outstanding

Loading...

Preferred Stock

Loading...

Treasury Stock Shares

Loading...

Stock Issuance & Repurchase

Loading...

Ownership Data

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013
Basic Shares Outstanding
Diluted Shares Outstanding
Preferred Stock
Treasury Stock Shares

Return On Shareholders' Equity

Loading...

Book Value

Loading...

Free Cash Flow

Loading...

Free Cash Flow YoY

Loading...

Free Cash Flow Margin

Loading...

Dividends

Dividends

Loading...

Stock Price

Loading...
Market Cap: $318.98 Million

About AC Immune SA

AC Immune SA is a clinical-stage biopharmaceutical company, which engages in the discovery and development of therapeutic and diagnostic products for neurodegenerative diseases. The company is headquartered in Lausanne, Vaud and currently employs 133 full-time employees. The company went IPO on 2016-09-23. The firm focuses on precision medicine for neurodegenerative diseases. The company designs, discovers and develops therapeutic, as well as diagnostic products for prevention, diagnosis and treatment of diseases caused by misfolding proteins. Its SupraAntigen and Morphomer technology platforms to create antibodies, small molecules and vaccines designed to address a broad range of neurodegenerative indications, such as Alzheimer's disease (AD). The firm's pipeline includes nine therapeutic product candidates with five in clinical trials, and three diagnostic candidates. Its lead product candidate is Crenezumab, a humanized and monoclonal anti-Abeta antibody for Alzheimer’s disease. The company has collaborations with pharmaceutical companies, including Roche/Genentech, Eli Lilly, Biogen, Janssen Pharmaceuticals, Nestle Institute of Health Sciences, Life Molecular Imaging (formerly Piramal Imaging) and Essex Bio-Technology.

Industry: Pharmaceutical Preparations Peers: ADC Therapeutics SA CRISPR Therapeutics AG VectivBio Holding AG